SLNO
SOLENO THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Latest reported
- Last report date
- May 7, 2026
- EPS actual
- $0.59
- EPS estimate
- $0.73
- Revenue actual
- $94.6M
- Revenue estimate
- $93.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +155.4%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 7, 2026 | $0.73 | $0.59 | Miss -19.18% | $94.6M |
| Feb 25, 2026 | $0.64 | $0.80 | Beat 25.00% | $91.7M |
| Nov 4, 2025 | $0.06 | $0.47 | Beat 717.39% | $66.0M |
| Feb 27, 2025 | -$0.63 | -$1.27 | Miss -101.59% | — |
| May 9, 2024 | -$0.30 | -$0.59 | Miss -96.67% | — |
| Mar 6, 2024 | -$0.31 | -$0.33 | Miss -6.45% | $3.4M |
| Mar 21, 2023 | -$0.76 | -$0.58 | Beat 23.68% | — |
| Aug 10, 2022 | -$1.05 | -$0.90 | Beat 14.29% | — |
| Mar 31, 2022 | -$1.20 | -$1.20 | In line | — |
| Nov 10, 2021 | -$1.65 | -$1.50 | Beat 9.09% | — |
| Jul 28, 2021 | -$1.20 | -$2.10 | Miss -75.00% | — |
| May 5, 2021 | -$0.60 | -$1.65 | Miss -175.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 7, 2026